vatalanib has been researched along with Experimental Mammary Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baum, O; Djonov, V; Gruber, G; Hlushchuk, R; Pruschy, M; Riesterer, O; Wood, J | 1 |
A'Hern, R; Banerjee, S; Detre, S; Dowsett, M; Evans, DB; Littlewood-Evans, AJ; Martin, LA | 1 |
Brasch, RC; Carter, WO; Floyd, E; Fu, Y; Novikov, V; Preda, A; Roberts, TP; Shames, DM; Turetschek, K; Wood, JM | 1 |
1 trial(s) available for vatalanib and Experimental Mammary Neoplasms
Article | Year |
---|---|
MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Contrast Media; Dextrans; Endothelial Growth Factors; Female; Ferrosoferric Oxide; Gadolinium DTPA; Intercellular Signaling Peptides and Proteins; Iron; Lymphokines; Macromolecular Substances; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mammary Neoplasms, Experimental; Mice; Oxides; Phthalazines; Pyridines; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
2 other study(ies) available for vatalanib and Experimental Mammary Neoplasms
Article | Year |
---|---|
Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation.
Topics: Actins; Animals; Antineoplastic Agents; Cell Proliferation; Immunohistochemistry; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Necrosis; Neovascularization, Pathologic; Phthalazines; Platelet Endothelial Cell Adhesion Molecule-1; Pyridines; Radiation, Ionizing; Time Factors; Tissue Survival; Up-Regulation; Xenograft Model Antitumor Assays | 2008 |
Biological evidence for dual antiangiogenic-antiaromatase activity of the VEGFR inhibitor PTK787/ZK222584 in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Cell Proliferation; Female; Humans; Immunohistochemistry; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neovascularization, Pathologic; Nitriles; Phthalazines; Pyridines; Receptors, Estrogen; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2010 |